CA
LMAT icon

Clearstead Advisors’s LeMaitre Vascular LMAT Stock Holding History

Clearstead Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$384 Buy
+4
New +$410 ﹤0.01% 3009
2025
Q1 		– Sell
-82
Closed -$7.56K – 2265
2024
Q4 		$7.56K Buy
82
+4
+5% +$385 ﹤0.01% 1646
2024
Q3 		$7.25K Hold
78
– – ﹤0.01% 1644
2024
Q2 		$6.42K Buy
78
+3
+4% +$220 ﹤0.01% 1644
2024
Q1 		$5.72K Buy
75
+39
+108% +$2.41K ﹤0.01% 1158
2023
Q4 		$2.04K Buy
+36
New +$1.89K ﹤0.01% 1281
2022
Q2 		– Sell
-38
Closed -$2K – 1372
2022
Q1 		$2K Buy
+38
New +$1.7K ﹤0.01% 1209

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Clearstead Advisors's LMAT Position: Q2 2026 in Review

Clearstead Advisors opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 4 shares worth $384. The stake represents ﹤0.01% of the portfolio and ranks #3009 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in LMAT as recently as Q4 2024.

Clearstead Advisors first reported a position in LMAT in Q1 2022 and has held it in 7 quarters since. The position peaked at $7.56K in Q4 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Clearstead Advisors held 4 shares of LeMaitre Vascular worth $384 as of Q2 2026.
  • LeMaitre Vascular was a new Clearstead Advisors position in Q2 2026.
  • LeMaitre Vascular made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3009 holding.
  • Clearstead Advisors first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 7 quarters since.
  • Clearstead Advisors's LeMaitre Vascular position peaked at $7.56K in Q4 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.